A phase I double-blind, randomised, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and immunogenicity of PolyCAb in healthy subjects following single doses and on cohort of multiple dosing

Trial Profile

A phase I double-blind, randomised, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and immunogenicity of PolyCAb in healthy subjects following single doses and on cohort of multiple dosing

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs PolyCAb (Primary)
  • Indications Clostridium infections
  • Focus Adverse reactions
  • Sponsors MicroPharm
  • Most Recent Events

    • 09 Mar 2017 Planned End Date changed from 31 Dec 2016 to 31 Mar 2017.
    • 09 Mar 2017 Status changed from completed to active, no longer recruiting.
    • 07 Mar 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top